A Fitbit got a reporter to see his doctor — and ultimately go under the knife. Are wearables the next wave in heart health?

Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...

Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...

Results from the single-arm trial saw 63.5% of patients able to avoid the symptoms of Atrial fibrillation over the course of ...

Smart healthtech wearable devices are trending but are these effective and accurate We reached out to a doctor who explained ...

We're talking about current issues in atrial fibrillation management. Professor Wellens, I've followed your work with great admiration over the years. Can you tell me how you see the field of ...

Atrial fibrillation (AF) is the most common arrhythmia seen in clinical practice, and is associated with increased morbidity and mortality. Management of AF is challenging due to the modest ...

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, ...

Medtronic (NYSE: MDT) today reported study results highlighting AFib detection with its Linq family of insertable cardiac monitors (ICM).

Johnson & Johnson’s JNJ MedTech unit has temporarily paused sales of Varipulse, its pulsed field ablation (PFA) therapy to treat atrial fibrillation (AFib) in the United States, as it ...